Related Experiment Video
Updated: Sep 16, 2025
Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
Published on: July 28, 2023
Evaluation of the Immunogenicity of a Mycobacterium intracellulare Clinical Isolate
Hongyang Duan1,2, Da Xu1, Yujie Gu1
1National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
What Is Already Known About This Topic?:
Nontuberculous mycobacteria (NTM) and Mycobacterium tuberculosis (MTB) share significant genomic similarity, enabling NTM to induce protective immune responses against MTB infection. This characteristic has led to their increasing application in tuberculosis (TB) vaccine development.
What Is Added By This Report?:
This study found mice in the experimental group developed high IgG antibody titers (1:921,600±446,351.3) and demonstrated a Th1-type immune response. Post-immunization serum antibodies exhibited cross-reactivity with MTB whole-cell proteins. Substantial neutrophil was recruited following antigen challenge. Mycobacterium intracellulare (Mit) whole-cell proteins demonstrate potent immunogenicity and cross-reactivity with MTB whole-cell proteins.
What Are The Implications For Public Health Practice?:
These findings suggest that potential applications in the immunoprevention and treatment of tuberculosis, and the Mit strain CHPC 1.5701 is identified as a promising candidate for tuberculosis vaccine development.
